Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine after acute myocardial infarction
ACTRN12615001194550Phase 4Completed
- Sponsor
- Royal Perth Hospital
- Start
- Feb 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Colchicine with Placebo (2 arms). Primary endpoint: Proportion of patients with CRP >= 2 mg/L at 30 days. Started Feb 2016; status: completed.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ACTRN12615001194550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001194550.